Suppr超能文献

使用 SMART-MSP 和 MS-HRM 对长达 30 年的福尔马林固定石蜡包埋(FFPE)组织进行基于 PCR 的甲基化分析的 DNA 质量评估。

Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM.

机构信息

Institute of Human Genetics, University of Aarhus, The Bartholin Building, Aarhus C, Denmark.

出版信息

BMC Cancer. 2009 Dec 21;9:453. doi: 10.1186/1471-2407-9-453.

Abstract

BACKGROUND

The High Resolution Melting (HRM) technology has recently been introduced as a rapid and robust analysis tool for the detection of DNA methylation. The methylation status of multiple tumor suppressor genes may serve as biomarkers for early cancer diagnostics, for prediction of prognosis and for prediction of response to treatment. Therefore, it is important that methodologies for detection of DNA methylation continue to evolve. Sensitive Melting Analysis after Real Time - Methylation Specific PCR (SMART-MSP) and Methylation Sensitive - High Resolution Melting (MS-HRM) are two methods for single locus DNA methylation detection based on HRM.

METHODS

Here, we have assessed the quality of DNA extracted from up to 30 years old Formalin Fixed Paraffin Embedded (FFPE) tissue for DNA methylation analysis using SMART-MSP and MS-HRM. The quality assessment was performed on DNA extracted from 54 Non-Small Cell Lung Cancer (NSCLC) samples derived from FFPE tissue, collected over 30 years and grouped into five years intervals. For each sample, the methylation levels of the CDKN2A (p16) and RARB promoters were estimated using SMART-MSP and MS-HRM assays designed to assess the methylation status of the same CpG positions. This allowed for a direct comparison of the methylation levels estimated by the two methods for each sample.

RESULTS

CDKN2A promoter methylation levels were successfully determined by SMART-MSP and MS-HRM in all 54 samples. Identical methylation estimates were obtained by the two methods in 46 of the samples. The methylation levels of the RARB promoter were successfully determined by SMART-MSP in all samples. When using MS-HRM to assess RARB methylation five samples failed to amplify and 15 samples showed a melting profile characteristic for heterogeneous methylation. Twenty-seven of the remaining 34 samples, for which the methylation level could be estimated, gave the same result as observed when using SMART-MSP.

CONCLUSION

MS-HRM and SMART-MSP can be successfully used for single locus methylation studies using DNA derived from up to 30 years old FFPE tissue. Furthermore, it can be expected that MS-HRM and SMART-MSP will provide similar methylation estimates when assays are designed to analyze the same CpG positions.

摘要

背景

高分辨率熔解(HRM)技术最近被引入作为一种快速而稳健的 DNA 甲基化分析工具。多个肿瘤抑制基因的甲基化状态可作为早期癌症诊断的生物标志物,用于预测预后和预测对治疗的反应。因此,检测 DNA 甲基化的方法不断发展非常重要。基于 HRM 的单基因座 DNA 甲基化检测的两种方法是实时 - 甲基化特异性 PCR 后灵敏熔解分析(SMART-MSP)和甲基化敏感 - 高分辨率熔解(MS-HRM)。

方法

在这里,我们评估了使用 SMART-MSP 和 MS-HRM 从长达 30 年的福尔马林固定石蜡包埋(FFPE)组织中提取的 DNA 进行 DNA 甲基化分析的质量。对来自 54 个非小细胞肺癌(NSCLC)样本的 DNA 进行了质量评估,这些样本来自 30 多年来收集的 FFPE 组织,分为 5 年间隔。对于每个样本,使用 SMART-MSP 和 MS-HRM 测定法估计 CDKN2A(p16)和 RARB 启动子的甲基化水平,这些测定法设计用于评估相同 CpG 位置的甲基化状态。这允许直接比较两种方法对每个样本估计的甲基化水平。

结果

在所有 54 个样本中均成功通过 SMART-MSP 和 MS-HRM 确定 CDKN2A 启动子的甲基化水平。两种方法在 46 个样本中获得相同的甲基化估计值。在所有样本中,成功通过 SMART-MSP 确定了 RARB 启动子的甲基化水平。当使用 MS-HRM 评估 RARB 甲基化时,五个样本未能扩增,15 个样本显示出异质甲基化的特征融解谱。在可以估计甲基化水平的 34 个样本中的 27 个,给出了与使用 SMART-MSP 观察到的相同的结果。

结论

MS-HRM 和 SMART-MSP 可成功用于使用长达 30 年的 FFPE 组织衍生的 DNA 进行单基因座甲基化研究。此外,可以预期当设计用于分析相同 CpG 位置的测定法时,MS-HRM 和 SMART-MSP 将提供相似的甲基化估计值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2d/2804714/8ce3bc96eccb/1471-2407-9-453-1.jpg

相似文献

2
4
Region of interest methylation analysis: a comparison of MSP with MS-HRM and direct BSP.
Mol Biol Rep. 2017 Jul;44(3):295-305. doi: 10.1007/s11033-017-4110-7. Epub 2017 Jul 4.
6
Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies.
Expert Rev Mol Diagn. 2010 Jul;10(5):575-80. doi: 10.1586/erm.10.46.
7
Closed-tube PCR methods for locus-specific DNA methylation analysis.
Methods Mol Biol. 2011;791:55-71. doi: 10.1007/978-1-61779-316-5_5.
9
Formalin-fixed, paraffin-embedded (FFPE) tissue epigenomics using Infinium HumanMethylation450 BeadChip assays.
Lab Invest. 2015 Jul;95(7):833-42. doi: 10.1038/labinvest.2015.53. Epub 2015 Apr 13.

引用本文的文献

1
Leveraging epigenetic aberrations in the pathogenesis of endometriosis: from DNA methylation to non-coding RNAs.
Front Genet. 2025 Jul 28;16:1597287. doi: 10.3389/fgene.2025.1597287. eCollection 2025.
2
The common bisulfite-conversion-based techniques to analyze DNA methylation in human cancers.
Cancer Cell Int. 2024 Jul 9;24(1):240. doi: 10.1186/s12935-024-03405-2.
4
Evaluation of whole-genome enrichment and sequencing of from FFPE samples after 75 years.
iScience. 2023 Dec 8;27(1):108651. doi: 10.1016/j.isci.2023.108651. eCollection 2024 Jan 19.
10
Translational Potential of Epigenetic-Based Markers on Fine-Needle Aspiration Thyroid Specimens.
Front Med (Lausanne). 2021 Mar 23;8:640460. doi: 10.3389/fmed.2021.640460. eCollection 2021.

本文引用的文献

2
Methylation-sensitive high-resolution melting.
Nat Protoc. 2008;3(12):1903-8. doi: 10.1038/nprot.2008.191.
6
A new approach to primer design for the control of PCR bias in methylation studies.
BMC Res Notes. 2008 Jul 28;1:54. doi: 10.1186/1756-0500-1-54.
7
DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients.
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):645-54. doi: 10.1158/1055-9965.EPI-07-2518.
9
Epigenetics in cancer.
N Engl J Med. 2008 Mar 13;358(11):1148-59. doi: 10.1056/NEJMra072067.
10
CpG islands: their potential as biomarkers for cancer.
Expert Rev Mol Diagn. 2007 Sep;7(5):519-31. doi: 10.1586/14737159.7.5.519.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验